Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela

被引：33
作者：
Calvo, BM
Colombo, AL
Fischman, O
Santiago, A
Thompson, L
Lazera, M
Telles, F
Fukushima, K
Nishimura, K
Tanaka, R
Myiajy, M
Moretti-Branchini, ML
机构：
[1] Univ Estadual Campinas, Div Infect Dis, Fac Ciencias Med, BR-13083970 Campinas, SP, Brazil
[2] Univ Zulia Luz, Maracaibo, Venezuela
[3] Hosp Clin Caracas, Caracas, Venezuela
[4] Clin Santa Maria, Santiago, Chile
[5] Chiba Univ, Chiba, Japan
[6] Fdn Oswaldo Cruz, Rio De Janeiro, Brazil
[7] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil
[8] Univ Fed Sao Paulo, Sao Paulo, Brazil
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 2001年 / 39卷 / 06期
关键词：
D O I：
10.1128/JCM.39.6.2348-2350.2001
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
One hundred clinical isolates of Cryptococcus neoformans from human immunodeficiency virus (HIV)-infected and non-HIV-infected patients from Brazil, Chile, and Venezuela were separated according to varieties and tested for antifungal susceptibility. A high susceptibility to antifungal agents was observed among all the isolates. The electrophoretic karyotyping of 51 strains revealed good discrimination among Cryptococcus neoformans var. neoformans strains.
引用
收藏
页码：2348 / 2350
页数：3
相关论文
共 11 条
[1]   Electrophoretic karyotype and in vitro antifungal susceptibility of Cryptococcus neoformans isolates from AIDS patients [J].
Barchiesi, F ;
Hollis, RJ ;
Messer, SA ;
Scalise, G ;
Rinaldi, MG ;
Pfaller, MA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 23 (03) :99-103
[2]   In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs [J].
Franzot, SP ;
Hamdan, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :822-824
[3]   Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: Evidence for both local genetic differences and a global clonal population structure [J].
Franzot, SP ;
Hamdan, JS ;
Currie, BP ;
Casadevall, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (09) :2243-2251
[4]   IMPROVED DIAGNOSTIC MEDIUM FOR SEPARATION OF CRYPTOCOCCUS-NEOFORMANS VAR NEOFORMANS (SEROTYPE-A AND SEROTYPE-D) AND CRYPTOCOCCUS-NEOFORMANS VAR GATTII (SEROTYPE-B AND SEROTYPE-C) [J].
KWONCHUNG, KJ ;
POLACHECK, I ;
BENNETT, JE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1982, 15 (03) :535-537
[5]  
LACAZ CS, 1991, MICOLOGIA MED FUNGOS, P545
[6]   CRYPTOCOCCOSIS IN THE ERA OF AIDS - 100 YEARS AFTER THE DISCOVERY OF CRYPTOCOCCUS-NEOFORMANS [J].
MITCHELL, TG ;
PERFECT, JR .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (04) :515-&
[7]  
National Committee for Clinical Laboratory Standards, 1997, M27A NAT COMM CLIN L
[8]   SEPARATION OF CHROMOSOMES OF CRYPTOCOCCUS-NEOFORMANS BY PULSED FIELD GEL-ELECTROPHORESIS [J].
PERFECT, JR ;
MAGEE, BB ;
MAGEE, PT .
INFECTION AND IMMUNITY, 1989, 57 (09) :2624-2627
[9]  
ROZEMBAUM R, 1992, MYCOPATHOLOGIA, V199, P133
[10]   CLINICAL EPIDEMIOLOGIC-STUDY OF 171 CASES OF CRYPTOCOCCOSIS [J].
ROZENBAUM, R ;
GONCALVES, AJR .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (03) :369-380
12